Advanex Inc.
Supplementary Financial Materials for Second Quarter of Fiscal Year Ending March 2027
Strong demand for automotive, medical, and aerospace markets drove year-on-year revenue growth and higher operating profit. Although a temporary foreign exchange loss was recorded, a special gain from the sale of the Singapore plant was also recognized. Consolidated cumulative 2Q revenue was 15,941 million yen and operating profit was 748 million yen. Full-year forecast: revenue 3,000,000 thousand yen, operating profit 1,500 million yen, net income 2,000 million yen. Dividend to be increased to 50 yen per share.
Key Figures
- Revenue (cumulative 2Q): 15,941 million yen
- Operating Income (cumulative 2Q): 748 million yen
- Net Income (attributable to owners of parent): 1,504 million yen
AI要約
Performance Overview
For the second quarter of the fiscal year ending March 2027, consolidated results showed year-on-year revenue growth, driven mainly by steady demand from the automotive, medical, and aerospace sectors. Despite continued upward pressure on crude oil and raw material costs and impacts from U.S. tariffs, operating income increased year-on-year. A special gain of 1,393 million yen was recognized from the sale of the Singapore plant (timely disclosure in August 2026). A foreign exchange loss of 178 million yen was recorded.
Outlook and Capital Allocation
Full-year forecast anticipates revenue of 3,000 million yen, operating income of 1,500 million yen, ordinary income of 1,200 million yen, and net income attributable to owners of parent of 2,000 million yen. The dividend policy plans a payout of 50 yen per share, representing an increase. The outlook takes into account special factors including the gain on the sale of the Singapore plant.
Revenue Trend
Operating Income Trend
Advanex Inc.
Company overview · Stock price · Financial data · All IR
